| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |